Novo Nordisk posts strong Q1 as weight-loss revolution claims another victim: WeightWatchers

fastcompany.com/91330270/novo-nordisk-posts-strong-q1-as-weight-loss-revolution-claims-another-victim-weightwatchers

One day after WeightWatchers said that it would file for bankruptcy, weight loss drug giant Novo Nordisk’s outlook is brightening.
Novo Nordisk, the Danish company that produces semaglutide drugs Ozempic and Wegovy, saw its shares rise more than 7% Wednesday, in spite of recent headwinds…

This story appeared on fastcompany.com, 2025-05-07 19:15:00.
The Entire Business World on a Single Page. Free to Use →